Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma

Pathology and Oncology Research

Volumn 11, Issue 2, 2005, Pages 74-81

  Croce, María V ^a   Rabassa, Martín E ^a   Pereyra, Adrián ^a   Segal Eiras, Amada ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Carbohydrate antigens; Head and neck carcinoma; MUC1; Sialic acid

Indexed keywords

EPITOPE; HAPTEN ANTIBODY; MONOCLONAL ANTIBODY; MUCIN 1; SIALIC ACID; SIALIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; SIALYLATION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

EID: 22844450292     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893370     Document Type: Article

References (44)

1. Bramwell ME, Wiseman G, Shotton DM: Electron-microscopic studies of the CA antigen, epitectin. J Cell Sci 86:249-261, 1986.
2. Brockhausen I, Yang J-M, Burchell J et al: Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem 223:607-617, 1995.
3. Bryne M, Gravdahi C, Koppang HS et al: Is the carbohydrate sialosyl-Tn a marker for altered, non-malignant activity in squamous epithelium in the head and neck region? J Pathol 175:237-242, 1995
4. Burchell J and Taylor-Papadimitriou J: Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol 2:115-162, 1993.
5. Ciborowski P, Konitzi WM, Magarian Blander J, et al: Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (Baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes. Tumor Biol 19 (Suppl 1):147-151, 1998.
6. Croce MV, Colussi A, Price MR, et al: Expression of tumor associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative study. Anticancer Res 17:4287-4292, 1997.
7. Croce MV, Rabassa ME, Price MR, et al: MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma. Pathol Oncol Res 7:284-291, 2001.
8. Croce MV, Isla-Larrain M, Rua C, et al: Patterns of MUC1 cytoplasmic tail monoclonal antibody in breast cancer. J Histochem Cytochem 5:1-8, 2003.
9. Dabelsteen E, Clausen H, Mandel U: Aberrant glycosylation in oral malignant and premalignant lesions. J Oral Path Med 20:361-368, 1991.
10. Dalziel M, Whitehouse C, Mcfarlane I, et al: The relative of the C2Gn T1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem 276:11007-11015, 2001.
11. Farmer RW, Richtsmeier WJ, Scher RL: Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Head Neck 20:726-731, 1998.
12. Feickert HJ, Anger BR, Cordón-Cardo C, et al: Cell-surface antigens of human tumors detected by mouse monoclonal antibodies: definition of blood-group- and non-blood-group-related antigenic systems. Int J Cancer 46:1007-1013, 1990.
13. Gendler SJ, Taylor-Papadimitriou J, Duhig T: A highly immunogenic region of human polymorphic mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263:12820-12823, 1988.
14. Gendler S: MUC1, the renaissance molecule. J Mamm Gland Biol Neoplasia 6:339-353, 2001.
15. Gleich LL, Ryzenman J, Gluckman JL et al: Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg 130:35-38, 2004.
16. Hakomori S-I: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257-331, 1989.
17. Ho JJL, Cheng S, Kim YS: Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Biochem Biophys Res Commun 210:866-873, 1995.
18. Irimura T, Denda K, Iida S, et al: Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity J Biochem 126:975-985, 1999.
19. Itoh T, Yonezawa S, Nomoto M, et al: Expression of mucin antigens and Lewis X-related antigens in carcinomas and dysplasia of the pharynx and larynx. Pathol Int 46:646-655, 1996.
20. Itzkowitz SH, Bloom EJ, Kokal WA, et al: Sialosyl Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66:1960-1966, 1990.
21. Jeannon J-P, Stafford FW, Soames JV, et al: Altered MUC1 and MUC2 glycoprotein expression in laryngeal carcinoma. Otolaryngol Head Neck 124:199-202, 2000.
22. Kam JL, Regimbald LH, Hilgers JH, et al: MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. Cancer Res 58: 5577-5581, 1998.
23. Kjeldsen T, Clausen H, Hirohashi S, et al: Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 48:2214-20, 1988.
24. Kunz H: Synthetic glycopeptides for the development of tumor-selective vaccines. J Pept Sci 9: 563-573, 2003.
25. Kurahara S, Shinohara M, Ikebe T, et al: Immunohistochemical study of sialyl Le(a) and sialyl Le(x) antigen in oral squamous cell carcinoma: the association of sialyl Le(a) expression with the metastatic potential. Head Neck 21:330-337, 1999.
26. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970.
27. Lloyd KL, Burchell J, Kudryashov V, et al: Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem 271:33325-33334, 1996.
28. Luna-Moré S, Rius F, Weil B, et al: EMA: a differentiation antigen related to node metastatic capacity of breast carcinomas. Pathol Res Pract 197:419-425, 2001.
29. Mandel U, Petersen OW, Sorensen H, et al: Simple mucin-type carbohydrates in oral stratified squamous and salivary gland epithelia. J Invest Dermatol 97:713-721, 1991.
30. Müller S and Hanisch F-G: Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. J Biol Chem 277:26103-26112, 2002.
31. Musselli C, Livingston PO, Ragupathi G: Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience. J Cancer Res Clin Oncol 127 (Suppl 2):R20-26, 2001.
32. Ogawa H, Ghazizadeh M, Araki T: Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma. Gynecol Obstet Invest 41:278-283, 1996.
33. Price MR, Pugh JA, Hudecz F, et al: C595 - a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Br J Cancer 61: 681-686, 1990.
34. Regimbald LH, Pilarski LM, Longenecker BM: The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 56:4244-4249, 1996.
35. Renkonen J, Paavonen T, Renkonen R: Endothelial and epithelial expression of sialyl Lewis x and sialyl Lewis a in lesions of breast carcinoma. Int J Cancer 74:296-300, 1997.
36. Rubin JS, Bloor BK, Hart IR, et al: muc-1 gene expression in head and neck squamous cell carcinoma. J Laryngol Otol 114:772-776, 2000.
37. Shi SR, Cote RJ, Taylor CR: Antigen retrieval techniques: current perspectives. Histochem Cytochem 49:931-937, 2001.
38. Spencer DI, Price MR, Tendler SJ, et al: Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. Cancer Lett 100:11-15, 1996.
39. Stenersen TC, Dabelsteen E: Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions. APMIS 27(Suppl):139-148, 1992.
40. Taylor-Papadimitriou J, Burchell J, Miles DW, et al: MUC1 and cancer. Biochim Biophys Acta 1455:301-313, 1999.
41. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979.
42. Wesseling J, van der Van SW, Vos HL, et al: Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129:255-265, 1995.
43. Zhang S, Walberg LA, Ogata S, et al: Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Cancer Res 55:3364-3368, 1995.
44. Zhang K, Baeckstrom D, Brevinge H, Hanasson GC: Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 60:538-549, 1996.